Compare Nebius Group NV (NBIS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs Health Care Select Sector SPDR Fund — how do they compare? Nebius Group NV trades at $221.12 (market cap $59.73B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Nebius Group NV is the larger of the two by market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nebius Group NV for 24 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| NBIS | XLV | |
|---|---|---|
Market Cap | $59.73B | $43.48B |
Volume | 21,563,700 | 11,121,431 |
Sector | Technology | — |
52-Week High | $286.69 | $175.68 |
52-Week Low | $73.87 | $141.95 |
Typical Hold Time | 24 Days | 100 Days |
Enterprise Value | $61.86B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NBIS trades at $219.71, down 7.32% today amid bearish technical signals, though recent quarterly earnings beat expectations. The company shows strong revenue growth with $530M in 2025 and $1.4B projected for 2026, but profitability remains challenged with a net margin of 3.13%. Analyst consensus is strongly bullish with 82% buy ratings and a $288.67 price target, representing 31% upside potential from current levels.
The stock presents significant growth potential driven by AI infrastructure demand and billion-dollar partnerships with Meta and Nvidia, but faces execution risks from aggressive expansion spending and high valuation multiples. Competitive pressures and insider selling activity warrant caution despite the compelling growth narrative in the AI cloud sector.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
